GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zafgen Inc (NAS:ZFGN) » Definitions » Dividends Received

Zafgen (Zafgen) Dividends Received


View and export this data going back to 2014. Start your Free Trial

What is Zafgen Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.


Zafgen (Zafgen) Business Description

Traded in Other Exchanges
N/A
Address
3 Center Plaza, Suite 610, Boston, MA, USA, 02108
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.